Article
Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug Development.
CPT: pharmacometrics & systems pharmacology - 1 May 2026
Ramesh Shyam S, Rogge Mark, Kim Jongjin, Kang Sanghoon, Kidd Kendrah, Williams Adrienne, Roignot Julie, Blakeslee Katherine, Bleyer Anthony J, Kim Sarah
Abstract excerpt
Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) is the third most common inherited monogenic kidney disorder. Mutations in UMOD and MUC1 account for most cases, with the disease characterized by progressive eGFR decline leading to kidney failure. No disease-modifying therapies exist, and transplantation is the only current option. Designing trials for ADTKD is hampered by small patient numbers,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
